In vitro cancer 3D models are valuable tools to provide mechanistic insight into solid tumor growth, invasion, and drug delivery. The 3D spheroid model of solid tumors has been the most popular cancer model in use until now. However, previous studies have shown that these spheroid models lack sufficient morphological parameters, which may affect their response to chemicals. In this work, we proposed the fabrication of miniaturized 3D cancer models using collagen type I-based bioprintable bioinks. In the context of a mimicking model for advanced neuroblastoma studies, we showed that cancer cells contained in bioprintable bioinks formed Homer Wright-like rosettes, maintained their proliferative capacities and produced an equivalent Vimentin-r...
Three-dimensional (3D) bioprinting allows the production of artificial 3D cellular microenvironments...
International audienceThree-dimensional cell culture has revolutionized cellular biology research an...
The in vitro evaluation of chemotherapeutic delivery systems is essential as a prediction of in vivo...
Tumor cells evolve in a complex and heterogeneous environment composed of different cell types and a...
Tissue-engineered scaffolds are more commonly used to construct three-dimension-al (3D) tumor models...
The tumor microenvironment (TME) typically comprises cancer cells, tumor vasculature, stromal compon...
International audienceThree dimensional (3D) bioprinting of multiple cell types within optimised ext...
The National Cancer Institute estimates that approximately 40% of men and women will be diagnosed wi...
Even with many advances in treatment over the past decades, cancer still remains a leading cause of ...
The complex and heterogenous nature of cancer contributes to the development of cancer cell drug res...
Innovative drug screening platforms should improve the discovery of novel and personalized cancer tr...
The bioprinting technique with specialized tissue production allows the study of biological, physiol...
The selection of a suitable matrix material is crucial for the development of functional, biomimetic...
‘Bioinks’ are important tools for the fabrication of artificial living-tissue constructs that are ab...
Abstract A series of stable and ready-to-use bioinks have been developed based on the xeno-free and ...
Three-dimensional (3D) bioprinting allows the production of artificial 3D cellular microenvironments...
International audienceThree-dimensional cell culture has revolutionized cellular biology research an...
The in vitro evaluation of chemotherapeutic delivery systems is essential as a prediction of in vivo...
Tumor cells evolve in a complex and heterogeneous environment composed of different cell types and a...
Tissue-engineered scaffolds are more commonly used to construct three-dimension-al (3D) tumor models...
The tumor microenvironment (TME) typically comprises cancer cells, tumor vasculature, stromal compon...
International audienceThree dimensional (3D) bioprinting of multiple cell types within optimised ext...
The National Cancer Institute estimates that approximately 40% of men and women will be diagnosed wi...
Even with many advances in treatment over the past decades, cancer still remains a leading cause of ...
The complex and heterogenous nature of cancer contributes to the development of cancer cell drug res...
Innovative drug screening platforms should improve the discovery of novel and personalized cancer tr...
The bioprinting technique with specialized tissue production allows the study of biological, physiol...
The selection of a suitable matrix material is crucial for the development of functional, biomimetic...
‘Bioinks’ are important tools for the fabrication of artificial living-tissue constructs that are ab...
Abstract A series of stable and ready-to-use bioinks have been developed based on the xeno-free and ...
Three-dimensional (3D) bioprinting allows the production of artificial 3D cellular microenvironments...
International audienceThree-dimensional cell culture has revolutionized cellular biology research an...
The in vitro evaluation of chemotherapeutic delivery systems is essential as a prediction of in vivo...